The Liver Meeting 2024 - Debrief Sessions - Portuguese-Hepatitis Debrief Session

Video Transcription

Video Summary

Dr. Tatiana Kushner provided a comprehensive debrief on recent developments in viral hepatitis research. Key highlights included the approval of point-of-care testing for hepatitis C and universal hepatitis B screening recommendations in the US. Dr. Kushner emphasized new insights into hepatitis B treatment, showing distinct outcomes for patients with different levels of viremia, suggesting a potential need for more aggressive treatment strategies aiming for undetectable viral DNA.<br /><br />In pediatrics, a study highlighted the successful treatment of hepatitis B using pegylated interferon in combination with NA therapy, showing a higher effectiveness in younger children. She also covered notable US and Asian adult studies on combination therapies involving pegylated interferon. Exciting developments include novel therapeutics in hepatitis B and delta, with emerging drug trials showing promise in achieving durable viral suppression and functional cures.<br /><br />For hepatitis C, Dr. Kushner stressed the need for improved treatment rates, spotlighting advances in therapy access and targeting difficult-to-reach populations, including pregnant individuals and younger demographics.

Keywords

viral hepatitis

hepatitis C testing

hepatitis B screening

pegylated interferon

novel therapeutics

treatment strategies